{"title":"锂治疗与甲状旁腺的相互作用","authors":"R. Tolouian, A. Baradaran","doi":"10.34172/jpd.2022.11178","DOIUrl":null,"url":null,"abstract":"Lithium is a trace element that has been commonly used in treating bipolar affective disorder for years. Lithium therapy causes renal failure, several endocrine and metabolic abnormalities, such nephrogenic diabetes insipidus, thyroid abnormalities, and hypercalcemia. Early detection of lithium-related hypercalcemia and primary hyperparathyroidism will ameliorate patients’ situations. Besides, regular serum calcium and parathormone assessment in individuals on lithium therapy is strongly recommended.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lithium therapy and parathyroid gland interaction\",\"authors\":\"R. Tolouian, A. Baradaran\",\"doi\":\"10.34172/jpd.2022.11178\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lithium is a trace element that has been commonly used in treating bipolar affective disorder for years. Lithium therapy causes renal failure, several endocrine and metabolic abnormalities, such nephrogenic diabetes insipidus, thyroid abnormalities, and hypercalcemia. Early detection of lithium-related hypercalcemia and primary hyperparathyroidism will ameliorate patients’ situations. Besides, regular serum calcium and parathormone assessment in individuals on lithium therapy is strongly recommended.\",\"PeriodicalId\":16657,\"journal\":{\"name\":\"Journal of Parathyroid Disease\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Parathyroid Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/jpd.2022.11178\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jpd.2022.11178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Lithium is a trace element that has been commonly used in treating bipolar affective disorder for years. Lithium therapy causes renal failure, several endocrine and metabolic abnormalities, such nephrogenic diabetes insipidus, thyroid abnormalities, and hypercalcemia. Early detection of lithium-related hypercalcemia and primary hyperparathyroidism will ameliorate patients’ situations. Besides, regular serum calcium and parathormone assessment in individuals on lithium therapy is strongly recommended.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
